Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Blue Bird Announces Amendment of Credit Facility: https://mms.businesswire.com/media/20210323005889/en/866918/5/Nuvve+%281%29+%28002%29.jpg
Blue Bird Announces Amendment of Credit Facility


Blue Bird Corporation (Nasdaq: BLBD), the leader in electric and low-emission school buses, announced today that it has entered into a fifth amendment to its credit facility, dated as of December

Groupon to Participate in the Goldman Sachs Communacopia + Technology Conference: https://mms.businesswire.com/media/20191104006028/en/466257/5/wordmark_one_cmyk.jpg
Groupon to Participate in the Goldman Sachs Communacopia + Technology Conference


Groupon, Inc. (NASDAQ: GRPN) announced that Kedar Deshpande, Chief Executive Officer, and Damien Schmitz, Interim Chief Financial Officer, will participate in the Goldman Sachs Communacopia +

Guidewire Announces Cincinnati Financial Corporation as new Guidewire Cloud Customer, Powering Top-Tier Insurer’s Claims Operations: https://mms.businesswire.com/media/20200616005489/en/798643/5/pr_20200616_aspen_launch-ASPEN-FINAL-BADGE.jpg
Guidewire Announces Cincinnati Financial Corporation as new Guidewire Cloud Customer, Powering Top-Tier Insurer’s Claims Operations


Guidewire (NYSE: GWRE) announced today that Cincinnati Financial Corporation has selected Guidewire ClaimCenter on Guidewire Cloud to power claims management for its insurance operations. The

Vistagen to Participate in Upcoming Morgan Stanley and Baird Healthcare Conferences: https://mms.businesswire.com/media/20220908005443/en/1564398/5/Vistagen_Primary-Logo_Blue.jpg
Vistagen to Participate in Upcoming Morgan Stanley and Baird Healthcare Conferences


Vistagen Therapeutics, Inc. (Nasdaq: VTGN) (Vistagen, the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety

OSSIAM US MINIMUM VARIANCE ESG NR UCITS ETF: Amendment of the definition of a business day
OSSIAM US MINIMUM VARIANCE ESG NR UCITS ETF: Amendment of the definition of a business day
OSSIAM US MINIMUM VARIANCE ESG NR UCITS ETF: Amendment of the definition of a business day
Kopin to Participate in Upcoming HC Wainwright 24th Annual Global Investment Conference
Kopin to Participate in Upcoming HC Wainwright 24th Annual Global Investment Conference


Kopin Corporation (NASDAQ: KOPN), a leading provider of innovative wearable computing technologies and solutions, announced today that Mr. Richard Sneider, Chief Financial Officer, will present at

Xencor Appoints Nancy Valente, M.D., to Board of Directors: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor Appoints Nancy Valente, M.D., to Board of Directors


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced the

Halfords Group PLC: Holding(s) in Company
Halfords Group PLC: Holding(s) in Company
Halfords Group PLC: Holding(s) in Company
AGCO to Present at the 2022 Morgan Stanley Laguna Conference: https://mms.businesswire.com/media/20191202006003/en/760023/5/agco_logo_w_descriptor2C.jpg
AGCO to Present at the 2022 Morgan Stanley Laguna Conference


AGCO, Your Agriculture Company (NYSE:AGCO), a worldwide manufacturer and distributor of agricultural equipment, infrastructure and precision ag technology, announced today that it will participate

Royal Gold Completes Acquisition of Great Bear Royalties Corp.: https://mms.businesswire.com/media/20191106005902/en/190143/5/Royal_Gold_Logo_-_no_shadow_-_Mar_07.jpg
Royal Gold Completes Acquisition of Great Bear Royalties Corp.


Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that its wholly owned subsidiaries, International Royalty Corporation

Form 8.3 - The Vanguard Group, Inc.: Vistry Group plc
Form 8.3 - The Vanguard Group, Inc.: Vistry Group plc
Form 8.3 - The Vanguard Group, Inc.: Vistry Group plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areatahttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata


Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug Application (NDA) for ritlecitinib for adults and adolescents 12 years of

Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Biffa plc
Form 8.3 - The Vanguard Group, Inc.: Biffa plc
Form 8.3 - The Vanguard Group, Inc.: Biffa plc